Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial

被引：0
|
作者：
Sehresh Hassan
Mohsin Shah
Muhammad Omar Malik
Ehtesham Ehtesham
Syed Hamid Habib
Bushra Rauf
机构：
[1] Khyber Medical University,Institute of Basic Medical Sciences
[2] Hayatabad Medical Complex,Department of Gynecology and Obstetrics
来源：
Endocrine | 2023年 / 79卷
关键词：
PCOS; Resveratrol; Myoinositol; Metformin; Pioglitazone; Adiponectin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：208 / 220
页数：12
相关论文
共 50 条
  • [31] Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
    Jamilian, Mehri
    Razavi, Maryamalsadat
    Kashan, Zohreh Fakhrie
    Ghandi, Yasser
    Bagherian, Tayebeh
    Asemi, Zatollah
    CLINICAL ENDOCRINOLOGY, 2015, 82 (06) : 885 - 891
  • [32] Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial - Reply
    Klumpp, TR
    Herman, JH
    Ackerman, SJ
    TRANSFUSION, 2000, 40 (03) : 384 - 384
  • [33] Oxidative Stress Response After Laparoscopic Versus Conventional Sigmoid Resection: A Randomized, Double-blind Clinical Trial
    Madsen, Michael Tvilling
    Kucukakin, Bulent
    Lykkesfeldt, Jens
    Rosenberg, Jacob
    Gogenur, Ismail
    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2012, 22 (03): : 215 - 219
  • [34] BRANCHED-CHAIN METABOLIC SUPPORT - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL IN SURGICAL STRESS
    CERRA, FB
    MAZUSKI, JE
    CHUTE, E
    NUWER, N
    TEASLEY, K
    LYSNE, J
    SHRONTS, EP
    KONSTANTINIDES, FN
    ANNALS OF SURGERY, 1984, 199 (03) : 286 - 291
  • [35] Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Kashani, Ladan
    Shams, Nazila
    Moazen-Zadeh, Ehsan
    Karkhaneh-Yousefi, Mohammad-Ali
    Sadighi, Gita
    Khodaie-Ardakani, Mohammad-Reza
    Rezaei, Farzin
    Rahiminejad, Fatemeh
    Akhondzadeh, Shahin
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 : 70 - 77
  • [36] The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
    ShadiSadat Seyyedebrahimi
    Hadi Khodabandehloo
    Ensieh Nasli Esfahani
    Reza Meshkani
    Acta Diabetologica, 2018, 55 : 341 - 353
  • [37] Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial
    Zamani, B.
    Golkar, H. R.
    Farshbaf, S.
    Emadi-Baygi, M.
    Tajabadi-Ebrahimi, M.
    Jafari, P.
    Akhavan, R.
    Taghizadeh, M.
    Memarzadeh, M. R.
    Asemi, Z.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (08)
  • [38] The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
    Seyyedebrahimi, ShadiSadat
    Khodabandehloo, Hadi
    Esfahani, Ensieh Nasli
    Meshkani, Reza
    ACTA DIABETOLOGICA, 2018, 55 (04) : 341 - 353
  • [39] Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Kouchaki, Ebrahim
    Tamtaji, Omid Reza
    Salami, Mahmoud
    Bahmani, Fereshteh
    Kakhaki, Reza Daneshvar
    Akbari, Elmira
    Tajabadi-Ebrahimi, Maryam
    Jafari, Parvaneh
    Asemi, Zatollah
    CLINICAL NUTRITION, 2017, 36 (05) : 1245 - 1249
  • [40] Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial
    Zamani, Batol
    Golkar, Hamid R.
    Farshbaf, Shima
    Emadi-Baygi, Modjtaba
    Tajabadi-Ebrahimi, Maryam
    Jafari, Parvaneh
    Akhavan, Reyhaneh
    Taghizadeh, Mohsen
    Memarzadeh, Mohammad R.
    Asemi, Zatollah
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) : 869 - 879
12345